Trade Association
Active 2015–2026. The register lists this client once for every firm that files on its behalf; all 2 of its records are shown together here.
These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | BGR GOVERNMENT AFFAIRS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2026 | BGR GOVERNMENT AFFAIRS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | |
| 2026 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | |
| 2026 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | |
| 2026 | BGR GOVERNMENT AFFAIRS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | |
| 2025 | BGR GOVERNMENT AFFAIRS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | |
| 2025 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | |
| 2025 | BGR GOVERNMENT AFFAIRS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2025 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION |
3rd Quarter (July 1 - Sep 30) AMENDED |
$50,000 | |
| 2025 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 |
| Firm | Filings | Amount |
|---|---|---|
| BGR GOVERNMENT AFFAIRS | 40 | $1,930,000 |
| PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION IN-HOUSE | 48 | $1,920,000 |
| Issue | Activities |
|---|---|
| Pharmacy | 75 |
| Manufacturing | 44 |
| Health Issues | 44 |
| Medical/Disease Research/Clinical Labs | 7 |
| Tariff (miscellaneous tariff bills) | 6 |
| Accounting | 1 |